Skip to content
Screener

aTyr Pharma ATYR Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$117.66B+22.9%
Merck & Co. logo
Merck & Co.MRK
$317.37B+57.4%
United Therapeutics logo
United TherapeuticsUTHR
$23B+75.9%
Rein Therapeutics Inc. logo
Rein Therapeutics Inc.RNTX
$36.45M
CTO
Citius Oncology, Inc.CTOR
$54.72M-17.8%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$656.19M+199%

Other financials

Income statement

See full
Revenue-
Operating income-$10.9M+46.4%
Net income-$10.3M+47.2%
EPS (diluted)-$0.11+50.0%

Balance sheet

See full
Cash & equivalents$16.2M-6.2%
Total debt$11.8M-10.7%
Total equity$48.8M-34.8%
Total assets$69.8M-31.2%

Cash flow

See full
Operating cash flow-$9.4M+32.7%
CapEx$73.0K+711%
Free cash flow-$9.4M+32.2%

Valuation

See full
Enterprise value$45.8M-90.4%

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-98.4%+18.0pp
Debt / equity0.2×+0.1×
Current ratio5.1×-0.5×

Where this comes from

Computed from the period-end share price: $58.52M.

The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001339970-26-000053

FAQ

What is aTyr Pharma's market capitalization?
aTyr Pharma (ATYR) reported market capitalization of $58.52M in Q2 2026.
How has aTyr Pharma's market capitalization changed year-over-year?
aTyr Pharma's market capitalization decreased by 87.6% year-over-year, from $472.61M to $58.52M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about aTyr Pharma's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude